Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Retinoid-Sensitive Epigenetic Regulation of the Hoxb Cluster Maintains Normal Hematopoiesis and Inhibits Leukemogenesis.

Cell stem cell | 2018

Hox genes modulate the properties of hematopoietic stem cells (HSCs) and reacquired Hox expression in progenitors contributes to leukemogenesis. Here, our transcriptome and DNA methylome analyses revealed that Hoxb cluster and retinoid signaling genes are predominantly enriched in LT-HSCs, and this coordinate regulation of Hoxb expression is mediated by a retinoid-dependent cis-regulatory element, distal element RARE (DERARE). Deletion of the DERARE reduced Hoxb expression, resulting in changes to many downstream signaling pathways (e.g., non-canonical Wnt signaling) and loss of HSC self-renewal and reconstitution capacity. DNA methyltransferases mediate DNA methylation on the DERARE, leading to reduced Hoxb cluster expression. Acute myeloid leukemia patients with DNMT3A mutations exhibit DERARE hypomethylation, elevated HOXB expression, and adverse outcomes. CRISPR-Cas9-mediated specific DNA methylation at DERARE attenuated HOXB expression and alleviated leukemogenesis. Collectively, these findings demonstrate pivotal roles for retinoid signaling and the DERARE in maintaining HSCs and preventing leukemogenesis by coordinate regulation of Hoxb genes.

Pubmed ID: 29727682 RIS Download

Research resources used in this publication

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


CD38 (antibody)

RRID:AB_1727473

This monoclonal targets CD38

View all literature mentions

Rabbit IgG Isotype Control (antibody)

RRID:AB_2532938

This isotype control targets Not Applicable

View all literature mentions

FITC anti-human Lineage Cocktail (CD3/14/19/20/56) (antibody)

RRID:AB_10644012

This monoclonal targets FITC anti-human Lineage Cocktail (CD3/14/19/20/56)

View all literature mentions

PE anti-mouse CD49b (antibody)

RRID:AB_313029

This monoclonal targets CD49b

View all literature mentions

CD11b/Mac-1 (antibody)

RRID:AB_396860

This monoclonal targets CD11b/Mac-1

View all literature mentions

CD45.2 (antibody)

RRID:AB_10897142

This monoclonal targets CD45.2

View all literature mentions

Rabbit IgG Isotype Control (antibody)

RRID:AB_2532938

This isotype control targets Not Applicable

View all literature mentions

CD11b/Mac-1 (antibody)

RRID:AB_396860

This monoclonal targets CD11b/Mac-1

View all literature mentions

CD38 (antibody)

RRID:AB_1727473

This monoclonal targets CD38

View all literature mentions

FITC anti-human Lineage Cocktail (CD3/14/19/20/56) (antibody)

RRID:AB_10644012

This monoclonal targets FITC anti-human Lineage Cocktail (CD3/14/19/20/56)

View all literature mentions

CD45.2 (antibody)

RRID:AB_10897142

This monoclonal targets CD45.2

View all literature mentions

PE anti-mouse CD49b (antibody)

RRID:AB_313029

This monoclonal targets CD49b

View all literature mentions